| Literature DB >> 29281981 |
Seon-Young Lee1, Harkiran Sagoo2, Reem Farwana3, Katharine Whitehurst4, Alex Fowler5, Riaz Agha6.
Abstract
BACKGROUND: Systematic reviews and meta-analyses are becoming increasingly important methods to summarize published research. Studies of ophthalmology may present additional challenges because of their potentially complex study designs. The aim of this study was to evaluate the reporting quality of systematic reviews and meta-analyses on topics in ophthalmology to determine compliance with the PRISMA guidelines. We assessed articles published between 2010 and 2015 in the five major relevant journals with the highest impact factors.Entities:
Keywords: Meta-analysis; Ophthalmology; PRISMA; Reporting quality; Research methodology; Systematic reviews
Mesh:
Year: 2017 PMID: 29281981 PMCID: PMC5745614 DOI: 10.1186/s12874-017-0450-1
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Flow diagram describing process of articles being reviewed and selected
Compliance with PRISMA checklist items (Table adapted from the PRISMA checklist, Moher et al.) [15]
| Section/Topic | No. | Brief description of the item | Compliance |
|---|---|---|---|
| TITLE | |||
| Title | 1 | Identification of the report | 62 (54%) |
| ABSTRACT | |||
| Structured summary | 2 | Provide a structured summary | 103 (90%) |
| INTRODUCTION | |||
| Rationale | 3 | Background rationale | 115 (100%) |
| Objectives | 4 | Description of PICOS (Participants, Interventions, Comparisons, and Study design) | 30 (26%) |
| METHODS | |||
| Protocol and registration | 5 | Indication of review protocol & registration information | 10 (9%) |
| Eligibility criteria | 6 | Specification of study and review characteristics used as eligibility criteria | 91 (79%) |
| Information sources | 7 | Describe all information sources and date last searched. | 97 (84%) |
| Search | 8 | Present repeatable full electronic search strategy for at least one database | 55 (48%) |
| Study selection | 9 | State the process for selecting studies | 86 (75%) |
| Data collection process | 10 | Describe the method of data extraction | 78 (68%) |
| Data items | 11 | Report all variables and any assumptions and simplifications made. | 77 (67%) |
| Risk of bias in individual studies | 12 | Describe the methods used to assess the risk of bias of individual studies | 46 (40%) |
| Summary measures | 13 | State the principal summary measures | 71 (62%) |
| Synthesis of results | 14 | Describe the methods used to handle and analyse the data | 53 (46%) |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence | 27 (24%) |
| Additional analyses | 16 | Describe methods of additional analyses | 38 (33%) |
| RESULTS | |||
| Study selection | 17 | Give numbers of studies at each stage of the study. | 73 (64%) |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted | 96 (84%) |
| Risk of bias within studies | 19 | Present data on risk of bias for each study | 42 (37%) |
| Results of individual studies | 20 | Report the summary of each data intervention group and estimates of confidence intervals | 65 (57%) |
| Synthesis of results | 21 | Present the results of each meta-analysis | 61 (53%) |
| Risk of bias across studies | 22 | Present the results of any assessment of risk of bias across studies | 35 (30%) |
| Additional analysis | 23 | Give the results of additional analyses | 33 (29%) |
| DISCUSSION | |||
| Summary of evidence | 24 | Summarize the main findings, including the strength of the evidence | 98 (85%) |
| Limitations | 25 | Discuss limitations at the study, outcome & review levels | 80 (70%) |
| Conclusions | 26 | Provide a general interpretation of the results | 110 (96%) |
| FUNDING | |||
| Funding | 27 | Describe sources of funding & other support | 85 (74%) |
| OVERALL ADHERENCE: 15 (56%) | |||
Fig. 2The number of articles according to their compliance range with the PRISMA criteria